查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2009166

乾眼症市場規模、佔有率、趨勢和預測：按疾病類型、藥物類型、產品類型、分銷管道和地區分類（2026-2034 年）

Dry Eye Syndrome Market Size, Share, Trends, and Forecast by Disease Type, Drug Type, Product, Distribution Channel, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

2025年全球乾眼症市場規模為52億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到80億美元，2026年至2034年的複合年成長率（CAGR）為4.83%。目前，北美市場佔據主導地位，預計到2025年將佔據超過55.0%的市場。北美市場成長的主要促進因素包括：龐大的老齡人口、各年齡層螢幕使用時間的增加、日益嚴重的環境污染以及不斷成長的消費者醫療保健支出。

眼科疾病，尤其是老年人眼部疾病的日益普遍，是推動市場成長的主要動力。老年人更容易患上乾眼症等慢性眼部疾病。由於電子設備普及導致螢幕使用時間增加，以及污染和氣候乾燥等環境因素的影響，乾眼症狀在各個年齡層的人群中越來越常見。此外，治療方案和診斷工具的進步，例如新型處方眼藥水、人工淚液和醫療設備，也正在擴大市場。醫療保健成本的上升和人們對眼睛健康的日益重視，也促進了早期發現和治療。

美國是該市場的主要驅動力，這主要得益於其眼科疾病的高發生率，尤其是在老年人群中。 50歲以上族群中，有相當一部分人會出現相關症狀。數位眼疲勞是乾眼症的重要風險因素，其盛行率因數位設備的廣泛使用、遠端辦公的興起以及螢幕使用時間過長而不斷上升。空氣污染和過度使用空調等環境因素也會加劇症狀。美國完善的醫療保健系統和廣泛的眼科保險覆蓋範圍，促進了尖端診斷和治療方案的普及。此外，美國眼科分析師協會（AOA）等機構所進行的教育計畫和宣傳活動，也推動了早期診斷和治療。根據IMARC Group的報告，預計到2032年，美國乾眼症市場規模將達到38億美元。

乾眼症市場趨勢：

老年人口增加

人口老化加劇是全球市場成長的重要促進因素。由於自然老齡化過程導致眼睛淚液分泌能力下降，乾眼症在老年人身上更為常見。此外，全球預期壽命的延長也導致老年人口不斷增加。這項變化直接影響著包括乾眼症在內的老齡化相關疾病的盛行率。同時，老年人更容易患慢性疾病，而用於治療這些疾病的藥物往往有加重乾眼症狀的副作用。因此，醫療保健系統面臨著對乾眼症診斷服務和治療（例如眼藥水、處方藥和專業眼科護理服務）日益成長的需求。

螢幕使用時間增加

各年齡層的螢幕使用時間增加是市場成長的關鍵促進因素。即使不計入職場中使用行動裝置的時間，上班族平均每天也要在電腦螢幕或筆記型電腦前花費 6.5 小時。此外，美國人平均每天的螢幕使用時間接近 11 小時，其中大部分發生在工作時間。現代生活方式高度依賴智慧型手機、平板電腦和電腦顯示器等電子螢幕。此外，遠距辦公的興起也增加了員工接觸電子螢幕的時間，導致眨眼頻率降低，進而引發眼睛乾澀。多項研究也表明，螢幕使用時間的增加與年輕人出現乾眼症症狀之間有強烈的相關性。因此，針對數位眼疲勞引起的乾眼症治療需求不斷成長，促使消費者在非處方人工淚液、處方藥以及緩解數位眼疲勞的設備上的支出增加。

環境污染日益惡化

環境因素在乾眼症市場擴張中也扮演著重要角色。根據世界衛生組織估計，全球約90%的人口暴露於空氣污染。在快速工業化的地區，空氣污染和極端天氣會加劇乾眼症的症狀。空氣污染物會刺激眼睛的嬌嫩組織，並且通常具有毒性，從而引發或加重乾眼症狀。此外，各種室內污染物，包括清潔產品、油漆和其他家用產品釋放的揮發性有機化合物（VOCs），會降低室內空氣質量，導致眼睛刺激和乾燥。此外，過敏體質的人對污染環境的過敏反應也會引發乾眼症狀。而且，環境污染會導致氣候變化，進而改變天氣模式和濕度水平。這些變化會顯著影響淚液蒸發速度，加重乾眼症狀，尤其是在乾燥地區。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球乾眼症市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場區隔：依疾病類型
  • 市場區隔：依藥物類型
  • 市場區隔：依產品分類
  • 市場區隔：依分銷通路分類
  • 市場區隔：按地區
  • 市場預測

第6章 市場區隔：依疾病類型分類

  • 蒸發性乾眼症
  • 水基乾眼症

第7章 市場區隔：依藥物類型分類

  • 抗發炎藥
  • 潤滑眼藥水
  • 自體血清眼藥水

第8章 市場區隔：依產品分類

  • 液滴
  • 凝膠
  • 液體擦拭巾
  • 眼膏
  • 其他

第9章 市場區隔：依分銷通路分類

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第10章 市場區隔：依地區分類

  • 北美洲
  • 歐洲
  • 亞太地區
  • 中東和非洲
  • 拉丁美洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

  • 價格指標
  • 價格結構
  • 利潤分析

第15章 製造過程

第16章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Akorn Operating Company LLC
    • Alimera Science
    • Allergan plc.
    • Auven Therapeutics
    • Bausch+Lomb Incorporated
    • GlaxoSmithKline plc
    • Nicox SA
    • Novartis AG
    • Otsuka Holdings Co., Ltd.
    • Santen Pharmaceutical Co., Ltd.
Product Code: SR112026A1136

The global dry eye syndrome market size was valued at USD 5.2 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 8.0 Billion by 2034, exhibiting a CAGR of 4.83% during 2026-2034. North America currently dominates the market, holding a significant market share of over 55.0% in 2025 . The high geriatric population, rising screen time among people of various age groups, increasing environmental pollution, and the growing consumer healthcare spending are some of the major factors propelling the market growth in North America.

The increasing incidence of eye-related illnesses, especially among the elderly population, which is more vulnerable to long-term ailments like dry eyes, represents one of the key factors supporting the growth of the market. Dry eye symptoms are becoming more common in several age groups as a result of increased screen time brought on by the widespread use of digital gadgets and environmental variables like pollution and arid regions. In addition, the market is expanding because of advancements in therapeutic solutions and diagnostic tools, such as novel prescription eye drops, artificial tears, and medical gadgets. Early identification and treatment are also being encouraged by rising healthcare costs and increasing awareness about eye health.

The United States stands out as a key market disruptor, driven by high prevalence of eye-related disorders, especially in its elderly population, with a notable proportion of those 50 years of age and older exhibiting symptoms. Digital eye strain is a significant risk factor for dry eye syndrome, and its prevalence is increasing due to the extensive use of digital devices, remote work patterns, and excessive screen time. The illness is getting worse by environmental factors, such air pollution and the extensive use of air conditioners (ACs). The adoption of cutting-edge diagnostic and treatment solutions is facilitated by the United States' strong healthcare system and widespread insurance coverage for eye care. Early diagnosis and treatment are also being encouraged by expanding education programs and awareness efforts run by groups like the American Optometric Association (AOA). The IMARC Group's report shows that the United States dry eye syndrome market is expected to reach US$ 3.8 Billion by 2032.

DRY EYE SYNDROME MARKET TRENDS:

Rising Geriatric Population

The increasing geriatric population is an important driver for the market growth around the world. Dry eye syndrome is more common in the geriatric population due to the natural aging process, which impacts the eye's ability to produce sufficient tears. Furthermore, countries across the globe are experiencing an increase in life expectancy, which, in turn, is increasing the geriatric population. This shift has a direct impact on the prevalence of age-related medical conditions, including dry eye syndrome. Besides this, geriatric adults are more susceptible to chronic health illnesses, and medications used for these conditions often have side effects that exacerbate dry eye symptoms. As a result, healthcare systems are facing an increased demand for both diagnostic services and treatments for dry eye syndrome, such as lubricating eye drops, prescription medications, and specialized eye care services.

Increasing Screen Time

The rising screen time among various age groups is a substantial factor fueling the market growth. Office workers spend an average of 6.5 hours each day in front of computer screens or laptops, excluding time spent on mobile devices at work. Additionally, Americans average nearly 11 hours of screen time per day, with the majority occurring during work hours. Modern lifestyles are dependent on digital screens, such as smartphones, tablets, and computer monitors. Furthermore, the emerging remote working culture is extending the exposure of employees to digital screens, which decreases the frequency of blinking, causing dryness in the eyes. Besides this, several studies are indicating a strong association between heightened screen time and symptoms of dry eye syndrome among young adults. Therefore, the escalating need for treatments targeting digital eye strain-induced dry eye is contributing to increased consumer spending on over the counter (OTC) artificial tears, prescription treatments, and devices designed to reduce digital eye strain.

Growing Environmental Pollution

Environmental factors also play an important role in the expansion of the dry eye syndrome market. The WHO estimates that approximately 90% of the global population is exposed to polluted air. Polluted air and extreme weather conditions in rapidly industrializing regions are exacerbating the symptoms of dry eye syndrome. In line with this, air pollution particles cause irritation and are often toxic to the eye's delicate tissues, thereby inducing or aggravating dry eye symptoms. Furthermore, various indoor pollutants, including volatile organic compounds (VOCs) emitted from cleaning products, paints, and other household items, reduce indoor air quality and lead to eye irritation and dryness. Besides this, allergic reactions from polluted environments can trigger dry eye symptoms in individuals who are susceptible to allergies. Moreover, environmental pollution contributes to climate change, which can alter weather patterns and humidity levels. These changes significantly affect tear evaporation rates and exacerbate dry eye symptoms, especially in arid regions.

DRY EYE SYNDROME INDUSTRY SEGMENTATION:

Analysis by Disease Type:

  • Evaporative Dry Eye Syndrome
  • Aqueous Dry Eye Syndrome

Evaporative dry eye syndrome leads the market with around 75.5% of market share in 2025. Due to its complex character and high incidence, evaporative dry eye syndrome (EDES) is the most common illness category. This illness is made worse by modern lifestyle choices like extended use of digital screens, increasing reliance on air conditioning (AC), and exposure to contaminants in the environment. Owing to physiological changes in gland function and tear production, the elderly population, a major demographic for eye disorders, is particularly vulnerable to EDES. Because the condition is chronic, it must be managed on time, which is driving the demand for therapeutic options like anti-inflammatory drugs, artificial tears, and cutting-edge therapies like thermal pulsation devices. Additionally, rising diagnosis rates owing to advancements in diagnostic technology and greater awareness about eye health are making EDES a common eye syndrome worldwide.

Analysis by Drug Type:

  • Anti-inflammatory Drugs
  • Lubricant Eye Drops
  • Autologous Serum Eye Drops

Anti-inflammatory drugs lead the market with around 53.3% of market share in 2025. As inflammation is a major contributing element to many eye problems, anti-inflammatory medications are the most common type of drugs in the market. Inflammation frequently aggravates symptoms and prevents recovery in conditions, such as dry eye syndrome, uveitis, and allergic conjunctivitis. These medications, which include cyclosporine, corticosteroids, and nonsteroidal anti-inflammatory medicines (NSAIDs), provide quick symptom relief by efficiently reducing discomfort, swelling, and redness. The need for anti-inflammatory therapy is increasing due to the rising incidence of chronic eye problems associated with age, extended screen time, and environmental irritants. Furthermore, improvements in medication formulations like sustained-release and preservative-free choices, are improving therapeutic results and patient compliance. Their market share is further supported by the growing awareness among the masses about eye health issues and the accessibility of both prescription and over-the-counter (OTC) anti-inflammatory medications.

Analysis by Product:

  • Liquid Drops
  • Gel
  • Liquid Wipes
  • Eye Ointment
  • Others

Liquid drops lead the market with around 59.3% of market share in 2025. Because of the versatility, effectiveness, and ease of use of liquid drops for a wide range of eye problems, they are the most popular product category in the eye syndrome market. Patients prefer liquid drops as a non-invasive solution for instant symptom alleviation, especially for dryness, irritation, and inflammation. They provide a range of products, such as antibiotic drops for infections, antihistamines for allergies, and artificial tears for dry eye condition. The need for these treatments is growing because of the rising incidence of diseases like dry eye syndrome, which are caused by environmental factors, digital screen usage, and aging populations. Furthermore, formulation developments including multi-dose vials and preservative-free alternatives are improving use and safety. Their dominance is further reinforced by their accessibility and cost, both through prescription drugs and over-the-counter (OTC).

Analysis by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Hospital pharmacies leads the market with around 56.3% of market share in 2025. Because they play a crucial role in delivering specialist eye care treatments and guaranteeing access to prescription pharmaceuticals, hospital pharmacies are the main distribution channel in the market for eye syndrome. They are the main source for recommended pharmaceuticals, such as antibiotics, anti-inflammatory drugs, and advanced therapies, as ophthalmologists frequently diagnose eye syndrome and develop treatment regimens for patients in hospital settings. These pharmacies have the benefit of providing quick access to necessary medications, particularly in circumstances that are urgent or severe. Hospital pharmacies are also reputable for upholding strict quality standards and providing a variety of specialty goods, such as compounded formulas for difficult situations. The dependence on hospital pharmacists is further fueled by the rising incidence of chronic eye disorders and increasing hospitalizations for diagnostic and treatment operations.

Regional Analysis:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

In 2025, North America accounted for the largest market share of over 55.0%. Owing to its sophisticated healthcare system, high incidence of eye conditions, and substantial expenditure in R&D, North America dominates the market for eye syndrome. The prevalence of diseases like dry eye syndrome is increasing in the region due to aging population, widespread use of digital screens, and environmental factors like pollution and air conditioning (AC). Furthermore, North America has a robust network of hospitals and clinics that specialize in ophthalmology, which facilitates prompt diagnosis and treatment. The market is further driven by the existence of top pharmaceutical businesses and continuous advancements in eye care goods like sophisticated treatments and diagnostic instruments. A significant part is also played by high healthcare costs, extensive insurance coverage, and heightened public awareness about eye health.

KEY REGIONAL TAKEAWAYS:

UNITED STATES DRY EYE SYNDROME MARKET ANALYSIS

In 2025, the dry eye syndrome market in the United States accounts for over 89% of the North American market share. It is drive by the high prevalence of dry eye disease , advanced healthcare infrastructure, and considerable R&D investment. Pharmaceutical innovations, including FDA-approved treatments like Xiidra and Restasis, are propelling the market growth. Telemedicine platforms are increasingly used for diagnosis and treatment of the condition. Further government initiatives, such as the National Eye Institute funding for research related to vision further fortify this market. Key players, such as Allergan and Novartis, are pushing ahead with the development of new therapies, including the latter's FDA-approved CEQUA, which is bolstering the growth of the market.

EUROPE DRY EYE SYNDROME MARKET ANALYSIS

Rising cases throughout Europe owing to an aging demography and increased screen time are positively influencing the European dry eye syndrome market. The EU's regulatory frameworks like CE Mark approval are facilitating the availability of novel therapies, including CEQUA, which entered the market in 2020. Awareness campaigns, such as those promoted by the European Dry Eye Society, call for early diagnosis and management. New diagnostic technologies, including the TearLab Osmolarity System, are being adopted for more precise assessments. Companies including Santen and Thea are expanding portfolios in preservative-free eye drops, long-term patient safety considerations, thereby strengthening the market growth.

ASIA PACIFIC DRY EYE SYNDROME MARKET ANALYSIS

The dry eye syndrome market in Asia Pacific is growing owing to factors like urbanization, lifestyle, and high health-care investment. Japan emerges as a significant market because of the aging population and advanced stages of health-care technologies. Demand for eye care service in China is increasing because of several factors including a demographic trend of aging population and high levels of eye diseases. Japan has been setting out its Vision 2030 to improve ophthalmologic care, while in China, the National Medical Products Administration is giving approval to newer treatments. Wearable diagnostics, along with health applications via mobiles, are helping tailor treatment for each individual, which is impelling the market growth.

LATIN AMERICA DRY EYE SYNDROME MARKET ANALYSIS

Latin America's dry eye syndrome market is expanding due to increased healthcare accessibility and the rising prevalence of chronic conditions. The adoption of teleophthalmology is rising, especially in remote areas, improving diagnosis and subsequent follow-up. International patients are attracted to Costa Rica, where it is possible to receive treatment for dry eye, a big earner for local medical tourism providers. Allergan's Restasis has a broad foothold in the market, although local makers were believed to be developing low-cost generic alternatives.

MIDDLE EAST AND AFRICA DRY EYE SYNDROME MARKET ANALYSIS

Dry eye syndrome in the Middle East and Africa is growing due to increasing investments in health and an increasing prevalence of the disease in dry climatic zones. Non-governmental organizations, such as Orbis International work alongside governments in Africa to make eye care more accessible. For example, in Ethiopia, in 2023, Orbis administered more than 8.8 million doses of the antibiotic azithromycin as part of efforts to eliminate trachoma, an infectious disease that can cause blindness. Meanwhile, they conducted more than 400,000 community eye screenings and examinations, attracting more than 192,000 patients for eye care services. Telemedicine is also highly adopted here, which presents challenges in rural areas and encourages early diagnosis.

COMPETITIVE LANDSCAPE:

Leading players are investing in creating new formulations, devices, and treatment methods to address different forms of dry eye syndrome more effectively. Furthermore, they are working with research institutions, other pharmaceutical companies, and healthcare providers to accelerate the development of new products and extend their market reach. Besides this, top firms are acquiring smaller companies with innovative technologies to diversify their product portfolio quickly and gain a competitive advantage. Additionally, companies are developing educational campaigns aimed at both healthcare providers and the public to raise awareness about the importance of early diagnosis and effective treatment, which, in turn, is increasing dry eye syndrome market revenue. Moreover, they are setting up manufacturing units, expanding distribution channels, and focusing on partnerships to tap into the growing demand for dry eye treatments in various geographical regions.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Akorn Operating Company LLC
  • Alimera Science
  • Allergan plc.
  • Auven Therapeutics
  • Bausch + Lomb Incorporated
  • GlaxoSmithKline plc
  • Nicox S.A.
  • Novartis AG
  • Otsuka Holdings Co., Ltd.
  • Santen Pharmaceutical Co., Ltd.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What is dry eye syndrome?

2. How big is the dry eye syndrome market?

3. What is the expected growth rate of the global dry eye syndrome market during 2026-2034?

4. What are the key factors driving the global dry eye syndrome market?

5. What is the leading segment of the global dry eye syndrome market based on the disease type?

6. What is the leading segment of the global dry eye syndrome market based on drug type?

7. What is the leading segment of the global dry eye syndrome market based on product?

8. What is the leading segment of the global dry eye syndrome market based on distribution channel?

9. What are the key regions in the global dry eye syndrome market?

10. Who are the key players/companies in the global dry eye syndrome market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Dry Eye Syndrome Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Disease Type
  • 5.5 Market Breakup by Drug Type
  • 5.6 Market Breakup by Product
  • 5.7 Market Breakup by Distribution Channels
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 Market Breakup by Disease Type

  • 6.1 Evaporative Dry Eye Syndrome
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Aqueous Dry Eye Syndrome
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 Anti-inflammatory Drugs
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Lubricant Eye Drops
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Autologous Serum Eye Drops
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Product

  • 8.1 Liquid Drops
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Gel
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Liquid Wipes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Eye Ointment
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 Global Dry Eye Syndrome Industry: SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Global Dry Eye Syndrome Industry: Value Chain Analysis

13 Global Dry Eye Syndrome Industry: Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Global Dry Eye Syndrome Industry: Price Analysis

  • 14.1 Price Indicators
  • 14.2 Price Structure
  • 14.3 Margin Analysis

15 Manufacturing Process

  • 15.1 Product Overview
  • 15.2 Raw Material Requirements
  • 15.3 Manufacturing Process
  • 15.4 Key Success and Risk Factors

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Akorn Operating Company LLC
    • 16.3.2 Alimera Science
    • 16.3.3 Allergan plc.
    • 16.3.4 Auven Therapeutics
    • 16.3.5 Bausch + Lomb Incorporated
    • 16.3.6 GlaxoSmithKline plc
    • 16.3.7 Nicox S.A.
    • 16.3.8 Novartis AG
    • 16.3.9 Otsuka Holdings Co., Ltd.
    • 16.3.10 Santen Pharmaceutical Co., Ltd.

List of Figures

  • Figure 1: Global: Dry Eye Syndrome Market: Major Drivers and Challenges
  • Figure 2: Global: Dry Eye Syndrome Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Dry Eye Syndrome Market: Breakup by Disease Type (in %), 2025
  • Figure 4: Global: Dry Eye Syndrome Market: Breakup by Drug Type (in %), 2025
  • Figure 5: Global: Dry Eye Syndrome Market: Breakup by Product (in %), 2025
  • Figure 6: Global: Dry Eye Syndrome Market: Breakup by Distribution Channel (in %), 2025
  • Figure 7: Global: Dry Eye Syndrome Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Dry Eye Syndrome Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 9: Global: Dry Eye Syndrome (Evaporative) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Dry Eye Syndrome (Evaporative) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Dry Eye Syndrome (Aqueous) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Dry Eye Syndrome (Aqueous) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Dry Eye Syndrome (Anti-inflammatory Drugs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Dry Eye Syndrome (Anti-inflammatory Drugs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Dry Eye Syndrome (Lubricant Eye Drops) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Dry Eye Syndrome (Lubricant Eye Drops) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Dry Eye Syndrome (Autologous Serum Eye Drops) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Dry Eye Syndrome (Autologous Serum Eye Drops) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Dry Eye Syndrome (Liquid Drops) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Dry Eye Syndrome (Liquid Drops) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Dry Eye Syndrome (Gel) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Dry Eye Syndrome (Gel) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Dry Eye Syndrome (Liquid Wipes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Dry Eye Syndrome (Liquid Wipes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Dry Eye Syndrome (Eye Ointment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Dry Eye Syndrome (Eye Ointment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Dry Eye Syndrome (Other Products) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Dry Eye Syndrome (Other Products) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Dry Eye Syndrome (Hospital Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Dry Eye Syndrome (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Dry Eye Syndrome (Retail) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Dry Eye Syndrome (Retail) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Dry Eye Syndrome (Online Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Dry Eye Syndrome (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: North America: Dry Eye Syndrome Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: North America: Dry Eye Syndrome Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Europe: Dry Eye Syndrome Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Europe: Dry Eye Syndrome Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Asia Pacific: Dry Eye Syndrome Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Asia Pacific: Dry Eye Syndrome Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Middle East and Africa: Dry Eye Syndrome Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Middle East and Africa: Dry Eye Syndrome Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Latin America: Dry Eye Syndrome Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Latin America: Dry Eye Syndrome Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Global: Dry Eye Syndrome Industry: SWOT Analysis
  • Figure 46: Global: Dry Eye Syndrome Industry: Value Chain Analysis
  • Figure 47: Global: Dry Eye Syndrome Industry: Porter's Five Forces Analysis
  • Figure 48: Dry Eye Syndrome Manufacturing: Process Flow

List of Tables

  • Table 1: Global: Dry Eye Syndrome Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Dry Eye Syndrome Market Forecast: Breakup by Disease Type (in Million USD), 2026-2034
  • Table 3: Global: Dry Eye Syndrome Market Forecast: Breakup by Drug Type (in Million USD), 2026-2034
  • Table 4: Global: Dry Eye Syndrome Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 5: Global: Dry Eye Syndrome Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 6: Global: Dry Eye Syndrome Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Dry Eye Syndrome: Raw Material Requirements
  • Table 8: Global: Dry Eye Syndrome Market Structure
  • Table 9: Global: Dry Eye Syndrome Market: Key Players